Glabridin

本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断

光甘草定可能通过在高血糖水平下调节 iNOS 的合成和活性，作为糖尿病相关血管功能障碍的抗炎剂。

Glabridin may serve as an anti-inflammatory agent in diabetes-related vascular dysfunction, through regulating the synthesis and activity of iNOS under high-glucose levels; may possess a therapeutic effect on metabolic disorders( such as diabetes and hyperglycemia), by modulating glucose metabolism through AMPK in skeletal muscle cells. Glabridin may have potential as a chemopreventive agent against liver Y metastasis, by inhibiting the invasion of human HCC cells.

——

——

Glabridin | Q-100692 | KB289522 | S-176045

Membrane Transporter/Ion Channel

NMDAR

T1 tyrosinase| T3 tyrosinase

Others-Field

——

59870-68-7

324.37

C20H20O4

>98% (HPLC)

DMSO : 150 mg/mL. 462.43 mM;

CC1(C=Cc2c(O1)ccc1c2OC[C@H](C1)c1c(cc(cc1)O)O)C

(R)-4-(8,8-dimethyl-3,4-dihydro-2H,8H-pyrano[2,3-f]chromen-3-yl)benzene-1,3-diol

(-20℃)

With Ice Pack

≥ 2 years